Company Overview of Salient Pharmaceuticals Incorporated
Salient Pharmaceuticals Incorporated engages in the development of a drug compound for the treatment of multiple inflammatory gastrointestinal (GI) conditions. It is developing CASAD, a drug for the treatment of cancer therapy-induced diarrhea, chronic conditions, infectious diseases, drug-related causes, and radiation therapy. The company was founded in 2007 and is based in Houston, Texas.
Houston, TX 77005
Founded in 2007
Key Executives for Salient Pharmaceuticals Incorporated
Similar Private Companies By Industry
|Praetego, Inc.||United States|
|1st Order Pharmaceuticals, Inc.||United States|
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
|NYC2012, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Salient Pharmaceuticals Incorporated, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.